Skip to content

8 Additional Assays for the Bayer Advia 1650 Chemistry System

by Bayer Corp.

510(k) K992662

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

Recall on shared 510(k) K992662; other models may be affected

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK992662 Date15 Feb 2000ClearedStatusActive

Recalls

1 recall · 1 ongoing · FDA

    • Ongoing Z-1003-2024 FDA Class II initiated 15 Dec 2023 on shared 510(k) K992662

    Potential for a negative bias with quality control (QC) and patient sample results when using the Atellica CH Immunoglobulin M_2 (IgM_2) reagent.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MSJ
Device Class
Class I
Regulation
21 CFR Part 862.1475
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Bayer Corp.

See all devices from Bayer Corp. →